Treatment for Early, Uncomplicated Coccidioidomycosis: What Is Success?
Authors:
- 23 September 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 70 (9) , 2008-2012
Abstract
The care of primary pulmonary coccidioidomycosis remains challenging. Such infections produce a variety of signs, symptoms, and serologic responses that cause morbidity in patients and concern in treating clinicians for the possibility of extrapulmonary dissemination. Illness may be due to ongoing fungal growth that produces acute inflammatory responses, resulting in tissue damage and necrosis, and for this, administering an antifungal drug may be of benefit. In contrast, convalescence may be prolonged by other immunologic reactions to infection, even after fungal replication has been arrested, and in those situations, antifungal therapy is unlikely to yield clinical improvement. In this presentation, we discuss what findings are clinical indicators of fungal growth and what other sequelae are not. Understanding these differences provides a rational management strategy for deciding when to continue, discontinue, or reinstitute antifungal treatments.Keywords
This publication has 32 references indexed in Scilit:
- Early Treatment With Fluconazole May Abrogate the Development of IgG Antibodies in CoccidioidomycosisClinical Infectious Diseases, 2011
- Factors and Outcomes Associated with the Decision to Treat Primary Pulmonary CoccidioidomycosisClinical Infectious Diseases, 2009
- Vaccine-Induced Cellular Immune Responses Differ from Innate Responses in Susceptible and Resistant Strains of Mice Infected withCoccidioides posadasiiInfection and Immunity, 2008
- Testing for Coccidioidomycosis among Patients with Community-Acquired PneumoniaEmerging Infectious Diseases, 2008
- Coccidioidomycosis as a Common Cause of Community-acquired PneumoniaEmerging Infectious Diseases, 2006
- Tissue Eosinophilia in Human CoccidioidomycosisClinical Infectious Diseases, 1982
- Pathology of Coccidioidomycosis1980
- The use of amphotericin B in the treatment of coccidioidal diseaseThe American Journal of Medicine, 1959
- PATTERN OF 39,500 SEROLOGIC TESTS IN COCCIDIOIDOMYCOSISJAMA, 1956
- Varieties of Coccidioidal Infection in Relation to the Epidemiology and Control of the DiseasesAmerican Journal of Public Health and the Nations Health, 1946